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Summary
Background—The incidence of HIV infection in young women in Africa is very high. We did a 
large-scale community-wide phylogenetic study to examine the underlying HIV transmission 
dynamics and the source and consequences of high rates of HIV infection in young women in 
South Africa.
Methods—We did a cross-sectional household survey of randomly selected individuals aged 15–
49 years in two neighbouring subdistricts (one urban and one rural) with a high burden of HIV 
infection in KwaZulu-Natal, South Africa. Participants completed structured questionnaires that 
captured general demographic, socioeconomic, psychosocial, and behavioural data. Peripheral 
blood samples were obtained for HIV antibody testing. Samples with HIV RNA viral load greater 
than 1000 copies per mL were selected for genotyping. We constructed a phylogenetic tree to 
identify clusters of linked infections (defined as two or more sequences with bootstrap or posterior 
support ≥90% and genetic distance ≤4.5%).
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Findings—From June 11, 2014, to June 22, 2015, we enrolled 9812 participants, 3969 of whom 
tested HIV positive. HIV prevalence (weighted) was 59.8% in 2835 women aged 25–40 years, 
40.3% in 1548 men aged 25–40 years, 22.3% in 2224 women younger than 25 years, and 7.6% in 
1472 men younger than 25 years. HIV genotyping was done in 1589 individuals with a viral load 
of more than 1000 copies per mL. In 90 transmission clusters, 123 women were linked to 103 
men. Of 60 possible phylogenetically linked pairings with the 43 women younger than 25 years, 
18 (30.0%) probable male partners were younger than 25 years, 37 (61.7%) were aged 25–40 
years, and five (8.3%) were aged 41–49 years: mean age difference 8.7 years (95% CI 6.8–10.6; 
p<0.0001). For the 92 possible phylogenetically linked pairings with the 56 women aged 25–40 
years, the age difference dropped to 1.1 years (95% CI –0.6 to 2.8; p=0.111). 16 (39.0%) of 41 
probable male partners linked to women younger than 25 years were also linked to women aged 
25–40 years. Of 79 men (mean age 31.5 years) linked to women younger than 40 years, 62 
(78.5%) were unaware of their HIV-positive status, 76 (96.2%) were not on antiretroviral therapy, 
and 29 (36.7%) had viral loads of more than 50 000 copies per mL.
Interpretation—Sexual partnering between young women and older men, who might have 
acquired HIV from women of similar age, is a key feature of the sexual networks driving 
transmission. Expansion of treatment and combination prevention strategies that include 
interventions to address age-disparate sexual partnering is crucial to reducing HIV incidence and 
enabling Africa to reach the goal of ending AIDS as a public health threat.
Funding—President’s Emergency Program for AIDS Relief, US Centers for Disease Control and 
Prevention, South African Medical Research Council, and MAC AIDS Fund.
Introduction
In southern and eastern Africa, the incidence of HIV in young women (aged <25 years) 
remains high, despite extensive prevention campaigns and scale-up of antiretroviral therapy 
(ART).1 The Joint UN Programme on HIV/AIDS (UNAIDS) has identified young women in 
these regions as the highest priority group for HIV prevention to help achieve the global goal 
of ending AIDS as a public health threat by 2030.1
A substantial imbalance in HIV prevalence exists between men and women throughout 
southern and eastern Africa, and women acquire HIV at a much earlier age than their male 
peers (appendix p 4). Although the reasons for these differences are not fully understood, the 
sexual network structure and dynamics might have prevalence2 suggest that older men are 
probably the main source of infection for young women, this suggestion has been disputed 
in two recent studies.3,4 However, findings from these studies were based on reported ages 
of male partners presumed to be the source of, or at least related to, HIV infections in 
women. The lack of clarity and definitive data on whether age-disparate sexual partnering is 
important for HIV transmission has hampered HIV prevention in southern and eastern 
Africa, which hosts more than 50% of the global HIV burden.1 Current prevention 
programmes in South Africa and several other countries have steered clear of including this 
sociobehavioural factor in their prevention messages and education programmes.
Current HIV prevention programmes have had limited impact on reducing HIV incidence in 
young women. Prevention strategies targeting the key underlying drivers of HIV 
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transmission could provide a more focused approach to HIV prevention in this high-risk 
group. Phylogenetic analysis can be used to identify drivers of HIV transmission, as seen in 
the ATHENA cohort study of men who have sex with men in the Netherlands.5 
Phylodynamic models can assess how transmission dynamics change over time, as used in a 
study in men who have sex with men in Detroit, USA.6 However, longitudinal cohorts with 
detailed clinical and behavioural data are rare in Africa.7
The purpose of our large-scale community-wide phylogenetic study was to examine the 
underlying HIV transmission dynamics and the source and consequences of high rates of 
HIV infection in young women in a district with a high burden of HIV in KwaZulu-Natal, 
South Africa. In this community, the reported incidence of HIV in women younger than 25 
years is 10.2 per 100 person-years (36 seroconversions during 353 person-years of follow-up 
in the placebo group of a microbicide trial).8
Methods
Study population
We did a household-based HIV survey in two neighbouring subdistricts (one urban and one 
rural) of the uMgungundlovu district of KwaZulu-Natal, South Africa. The household 
survey is described in detail in the study protocol.9 In summary, this was a cross-sectional 
survey of randomly selected individuals aged 15–49 years (appendix p 2). We used 
multistage sampling to randomly select households and recruit a household-representative 
sample of men and women. The primary sampling unit was the enumeration area, the 
secondary sampling unit was household, and the tertiary sampling unit was the individual 
within a household. 221 of 591 enumeration areas were drawn randomly, and households 
within each enumeration area were identified by a global positioning system. In the selected 
households, one individual was selected at random to be included in the study. Eligible 
participants received study information and provided written informed consent (or parental 
consent and assent if aged <18 years) in the preferred language of English or isiZulu before 
enrolment in the study.
The study was approved by the Biomedical Research Ethics Committee, University of 
KwaZulu-Natal; the US Centers for Disease Control and Prevention; and the KwaZulu-Natal 
Provincial Department of Health.
Procedures
Each participant was assigned a unique study number linked to the structured questionnaires 
that captured general demographic, socioeconomic, psychosocial, and behavioural data. This 
information included, but was not limited to, self-reported HIV testing history, ART use, 
sexually transmitted infections, and male circumcision status.
Peripheral blood samples were collected by trained staff. HIV antibody testing was done 
with the HIV enzyme Vironostika HIV Uniform II Antigen/Antibody microELISA system 
(BioMérieux, Marcy l’Étoile, France) and Elecsys HIV 1/2 combi PT assay (Roche 
Diagnostics, Penzberg, Germany). Samples that produced an indeterminate result were 
resolved using the ADVIA Centaur HIV Antigen/Antibody Combo (CHIV) assay (Siemens, 
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Tarrytown, NY, USA). HIV antibody-positive samples were confirmed with the HIV-1 
Western Blot assay (Bio-Rad Laboratories, Redmond, WA, USA). HIV antibody-negative 
samples were also tested with a pooled nucleic acid amplification test for detection of HIV-1 
RNA using the COBAS AmpliPrep/COBAS TaqMan HIV-1 version 2.0 assay (Roche), in 
pools of ten samples. Pooled samples testing positive were disaggregated and retested 
individually. For all HIV-1-positive samples, CD4 cell counts were measured by BD 
FACSCalibur flow cytometry (BD Biosciences, San Jose, CA, USA). Viral loads were 
determined for all HIV-positive samples with the COBAS AmpliPrep/COBAS TaqMan 
HIV-1 version 2.0 assay.
Samples with HIV RNA viral loads greater than 1000 copies per mL were selected for 
genotyping (1589 sequences generated), which was done in three accredited laboratories in 
South Africa—namely, the National Institute of Communicable Diseases (NICD) HIV 
Genotyping Laboratory in Johannesburg (194 sequences), the Wellcome Trust Africa Centre 
for Population Health Virology Laboratory in Durban (685), and the Global Clinical Viral 
Laboratory in Durban (710). The inter-laboratory quality control procedure between the 
Global Clinical Viral Laboratory and the NICD generated nearly identical (mean pairwise 
distance at nucleotide level 0.000 [range 0.000–0.002] and aminoacid level 0.001 [range 
0.000–0.006]) sequences for the random sample of 14 (0.9%) plasma specimens tested in 
both laboratories. Overall, the analysis showed sufficient nucleotide and aminoacid 
similarity between pairs of sequences to pass the inter-laboratory validation process. The 
Africa Centre for Population Health Virology Laboratory participates in an external 
proficiency testing programme of the French National Agency for Research on AIDS and 
Viral Hepatitis (ANRS).
All three laboratories generated HIV-1 sequences using the SATuRN/Life Technologies 
genotyping system,10 with standard operating procedures common to all three laboratories. 
In short, this protocol uses four sequencing primers for the generation of the 1197 bp pol 
sequence covering all 99 HIV-1 protease codons and the first 300 codons of the reverse 
transcriptase gene. Geneious software was used for sequence assembly of the Sanger 
electropherogram reads. The viral sequences were analysed using the HIV-1 Quality 
Analysis Tool (For more on the HIV-1 Quality Analysis Tool see http://www.bioafrica.net/
software.php) and the Calibrated Population Resistance (CPR) tool11 to identify sequencing 
problems such as frameshifts, stop codons, and unusual polymorphisms. To further identify 
potential contamination, the generated sequences were compared with a local BLAST 
database, which included 11 500 unique sequences.12 Sequences with more than 98% 
identity to sequences in the database were regarded as potential contaminants. For all 
potential contaminants, the laboratory where they were produced as well as the RNA 
extraction and sequencing dates were identified. If the RNA extraction or sequencing 
happened on the same day, the RNA was re-extracted and resequenced at different dates or 
different laboratories, or both. Sequences that did not pass this quality step were not used for 
the construction of the phylogenetic tree. HIV subtyping was done with the REGA HIV-1 
Subtyping Tool (version 3.0) and by maximum likelihood phylo- genetic confirmation. All 
but five of the 1589 sequences were subtype C.
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HIV-1 sequences were aligned using MAFFT13 and visually inspected in AliView.14 The 
alignment was edited manually until a perfect codon-based alignment was produced. A 
maximum likelihood tree was reconstructed using FastTree15 through a computer cluster of 
the Centre for High Performance Computing at the University of KwaZulu-Natal. The model 
of evolution was estimated from the dataset with ModelTest. The selected model was the 
general time reversible substitution model16 with γdistributed rate variation among sites.17 
To assess the clade support, we applied the Shimodaira-Hasegawa approximate likelihood 
ratio test (SH-aLRT) with 1000 pseudo-replicates. To refine the topology, we re-estimated 
the maximum likelihood tree with 100 extra rounds of branch moves. This process was done 
with both nearest-neighbour interchanges and subtree-prune- regraft tree topology operators, 
as applied in FastTree.
HIV-1 transmission clusters were identified from the maximum likelihood tree with the 
ClusterPicker software application.18 We defined a transmission cluster as any clade with a 
support higher than 90% (SH-aLRT) and whose sequences had an intraclade genetic 
distance of less than or equal to 4.5%, parameters that are commonly used for the 
identification of transmission clusters.5,18 Phylogenetic linkage was regarded as the relation 
between two or more individuals within a cluster and, hence, were probable nodes within a 
transmission network. Every sequence within each cluster had to be connected to another 
sequence by less than or equal to 4.5% genetic distance; the mean genetic diversity was 
2.8% and the mean branch support was 99.6%. All sequences that were identified in 
phylogenetic clusters were extracted and a confirmatory phylogenetic analysis done. This 
analysis involved the construction of a maximum likelihood phylogenetic tree with 1000 
bootstraps using PhyML, with the same substitution model (general time reversible with γ-
distributed rate variation among sites) as used for the initial FastTree-constructed 
phylogenetic tree. Additionally, we used MrBayes to construct a second phylogenetic tree 
with Bayesian methods. Because this Bayesian tree did not differ from the maximum 
likelihood tree, only the latter was analysed further. The maximum likelihood tree was 
analysed with ClusterPicker with the previously described parameters (ie, branch support 
>90% and genetic distance ≤4.5%) and compared with epidemiological data by use of 
ClusterMatcher.18 Lastly, trees were visualised and annotated with key demographic and 
epidemiological data in FigTree.
Directionality of transmission was assessed through a stratified age and sex prevalence 
analysis based on the probability of one sampled individual transmitting to another within a 
cluster being a function of the sequencing coverage and the prevalence in the population.6 
Within each cluster, all possible pairings were identified and stratified by age of women and 
male partner’s age into three categories (<25 years, 25–40 years, and >40 years), on the 
basis of previous HIV prevalence rates in this community, thereby generating nine groups of 
age–sex pairings. We calculated the number of pairings in each of the nine groups and the 
groups that constituted most pairings were analysed for directionality by determining 
whether men or women had higher HIV prevalence.
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Taking into account the complex multilevel sampling approach and adjusting for non-
response, weighted data were analysed with SAS version 9.4 survey procedures (see 
appendix for details of sample size calculation and weighting procedures). Two-sample t 
tests or Kruskal-Wallis non-parametric tests, and χ² or Fisher’s exact tests, were used to 
compare continuous and categorical descriptive outcomes, respectively.
Role of the funding source
The funders of the study had no role in study design, data collection, data analysis, data 
interpretation, or writing of the report. ABMK, TdO, TG, SSAK, and AG had full access to 
all the data in the study. ABMK, TdO, and SSAK had final responsibility for the decision to 
submit for publication.
Results
Enrolment for the study began on June 11, 2014, and ended on June 22, 2015. 14 618 
households were eligible; of these, 2144 (14.7%) heads of households refused to take part in 
the study, 753 (5.2%) households had no one at home after three visits, and 432 (3.0%) 
households had no one home after the first visit, but were never revisited because the 
protocol-specified sample size was met before they needed to be. 11 289 (77.2%) 
households were enrolled, 398 of whom did not have an eligible person living in the 
household. 10 891 potentially eligible individuals were approached for participation in the 
study; 577 (5.3%) refused to take part (246 men and 331 women), 488 (4.5%) were still in 
the process of completing enrolment when the study ended, and 14 (0.1%) had no HIV 
results available. 9812 individuals were enrolled and tested for HIV, of whom 3969 (40.5%) 
were HIV positive (weighted 36.3%, 95% CI 34.8–37.8; table 1). 2955 (47.2%) of 6265 
women (44.1%, 42.3–45.9) had HIV compared with 1014 (28.6%) of 3547 men (28.0%, 
25.9–30.1; p<0.0001; table 2). HIV prevalence was 62.0% (1758 of 2835; weighted 59.8%) 
in women aged 25–40 years and was highest in those aged 35–39 years (517 [68.0%] of 760; 
weighted 66.4%; figure 1). In individuals younger than 25 years, HIV prevalence was about 
three times higher in women than in men (p<0.0001; table 2).
1592 (40.1%; weighted 42.3%) of the 3969 HIV-positive individuals reported that they were 
on ART (table 1), coverage that was similar to national treatment coverage in ART-eligible 
individuals at the time of the study.1 1412 (88.8%; weighted 88.3%) of 1590 participants 
who reported using ART and whose viral loads were tested had HIV RNA viral loads of less 
than 1000 copies per mL, whereas 697 (29.5%; weighted 27.1%) of 2366 individuals who 
reported that they were not on ART had viral loads less than 1000 copies per mL. 13 HIV-
positive individuals had samples insuffcient for viral load testing. 2292 (57.9%; weighted 
58.0%) of the 3956 HIV-positive individuals whose viral loads were tested had detectable 
viral loads of at least 20 copies per mL; 1847 (46.5%) had more than 1000 copies per mL 
and were selected for sequencing (table 1).
Blood samples were available from 1688 individuals whose viruses were selected for 
sequencing. The viruses of 95 of these individuals could not be sequenced and four 
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sequences did not pass the quality control step, resulting in 1589 pol sequences of 1200 bp 
for 86.0% of the individuals with viral loads of more than 1000 copies per mL. Applying the 
criteria of more than 90% SH-aLRT clade support and genetic distance of less than or equal 
to 4.5%, 469 (29.5%) sequences grouped into 202 transmission clusters (see appendix p 3 
for cluster size distribution). 151 (32.2%) of the 469 sequences were from men and 318 
(67.8%) were from women, reflecting the sex distribution in the whole sequenced dataset 
(1102 women and 487 men).
90 of the 202 clusters had at least one woman and one man (figure 2). 123 women were 
linked to 103 men in the 90 clusters. Within these clusters, 43 (35.0%) women were younger 
than 25 years, 56 (45.5%) were aged 25–40 years, and 24 (19.5%) were older than 40 years.
49 women (39.8%) were aware of their serostatus compared with 27 men (26.2%; p=0.035; 
table 1). Because only individuals with viral loads of more than 1000 copies per mL are 
included in this analysis, the small numbers of people in transmission clusters who reported 
being on ART were expected (table 1). Median viral load was significantly higher in men 
than in women (31 000 copies per mL in men vs 16 629 copies per mL in women; p=0.002); 
41 (33.3%) women and 37 (35.9%) men had viral loads of more than 50 000 copies per mL.
In the 90 clusters, there were 188 possible pairings between the 123 women and 103 men. A 
comparison of all possible pairings across age and sex categories (figure 3) identified two 
more frequent sets of linkages: between women aged 25–40 years and men aged 25–40 
years (58 [30.9%] pairings) and between women younger than 25 years and men aged 25–40 
years (37 [19.7%] pairings]), which constituted just over 50% of the linkages. In the 60 
possible pairings between the 43 women younger than 25 years who were linked to 41 
probable male partners, the mean age difference was 8.7 years (95% CI 6.8–10.6; 
p<0.0001). In these 60 possible pairings, 18 (30.0%) of the probable male partners were 
younger than 25 years, 37 (61.7%, 95% CI 49.7–74.3) were aged 25–40 years, and five 
(8.3%) were aged 41–49 years. Of the 41 probable male partners linked to a woman younger 
than 25 years, 16 (39.0%) were also linked to a 25–40-year-old woman (figure 4); the mean 
age of these male partners was 29.6 years (SD 7.1) and they were linked to both a younger 
woman (mean age 22.1 years) and an older woman (mean age 32.6 years). In the 92 possible 
pairings between the 56 women aged 25–40 years who were linked to 36 probable male 
partners, the mean age difference was 1.1 years (95% CI–0.6 to 2.8; p=0.111). Of 79 men 
(mean age 31.5 years) linked to women younger than 40 years, 62 (78.5%) were unaware of 
their HIV-positive status, 76 (96.2%) were not on ART, and 29 (36.7%) had viral loads of 
more than 50 000 copies per mL.
The mean age of male partners of HIV-positive women aged 20 years or younger was 30.5 
years; the mean age difference was 11.5 years (SD 7.8; p<0.0001). The age gap decreased to 
a mean difference of 7.0 years (SD 6.7) in HIV-positive women aged 21–25 years and to a 
mean difference of 1.5 years (SD 9.1) in women aged 26–30 years (table 3).
The age gap between HIV-negative women and their self-reported male partners (not linked 
through clustering) was smaller (plus or minus 3.8 years) and more consistent across the age 
groups. Educational levels, age of sexual debut, number of lifetime and current sexual 
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partners, sexual frequency, and condom use were similar in the various subpopulations, 
irrespective of HIV status and linkage in clusters (table 1). Overall, the sample included 4% 
of the census-defined population. Sequencing coverage of HIV-positive individuals in the 
sample was higher than 25% in all age categories, being highest in men (402 [52.4%; 
weighted 51.3%] of 767) and women (926 [39.8%; weighted 36.5%] of 2325) aged 40 years 
and younger (table 2). Since sequencing coverage was not skewed and there is no evidence 
of super-spreaders driving HIV transmission in the opposite direction to the prevalence 
gradient, the dominant directionality of transmission was determined to occur from the 
highest prevalence of 59.8% (women aged 25–40 years) to 40.3% (probable male partners 
aged 25–40 years) to 22.3% (women aged <25 years; table 2, figures 3 and 4).
Discussion
Phylogenetic linkage, together with prevalence gradients, suggest that men aged 25–40 years 
were the primary source of the high rates of HIV acquisition in adolescent girls and young 
women (15–25 years). Many of these men had acquired HIV infection from women aged 
25–40 years, which is the group with the highest prevalence of HIV. Over time, when the 
current group of adolescent girls and young women reach their 30s, we expect that they will 
then constitute the next group of women with high HIV prevalence, thereby perpetuating the 
cycle of HIV transmission to men in their 30s who will infect the next cohort of adolescent 
girls and young women (figure 4). The risks of HIV transmission within this cycle are 
enhanced at a community level by two key factors. First, two-fifths of HIV-positive 
individuals in this community were not aware of their HIV-positive status, and second, only 
two-thirds of individuals who knew they had HIV had initiated ART, resulting in suboptimal 
viral suppression. In particular, many of the men linked to women in the dual age groups (ie, 
<25 years and 25–40 years) were likely to have recently acquired HIV, were unaware of their 
HIV status, and had viral loads associated with high rates of transmission.19
Our results differ from those reported elsewhere; age disparity was not a risk factor for HIV 
acquisition in either a cohort study in which women reported the age of their most recent 
sexual partner on a yearly basis3 or in a clinical trial in which the age of a single primary 
partner was reported by women at baseline for infections occurring up to a year later.4 The 
major shortcoming in both studies is that the men whose ages were analysed might not have 
been the source of the women’s HIV exposure or infection. Investigators of both studies 
were unable to determine accurately which men transmitted HIV to the women enrolled.
Rapidly advancing bioinformatics methods such as phylogenetics20 and phylodynamics12,21 
overcome this limitation and provide information about clearly linked individuals within a 
transmission cluster. A strength of our approach is that the phylogenetic clusters minimise 
the assumptions required to identify the chains of transmission. However, an important 
assumption remains; that viral transmission occurred among linked individuals within a 
cluster, acknowledging that not all partners in a chain of transmission may have been 
included in a cluster.
Our study also has several weaknesses. First, although this was a large cross-sectional study, 
our sample of 9812 individuals consisted of only 4% of the population, limiting the extent to 
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which we were able to uncover linkages. Since the 4% sample was representative, we have 
extrapolated its findings to the community, in recognition of the limitations of this sample 
size.
Second, we did not have detailed longitudinal, clinical, and behavioural data to assist in 
establishing directionality. We therefore inferred directionality on the basis of the prevalence 
gradients, which is a crude approach and might not apply uniformly across the 188 possible 
pairings in the 90 male–female clusters. Although it is a reasonable assumption that most 
transmission will probably occur from high to low prevalence, we were not able to quantify 
the exact proportion of transmissions occurring against the gradient. However, there was no 
evidence of super-spreaders to drive transmission against the prevalence gradient.
Third, our study sampled an urban and a neighbouring rural community from one province 
in one country and is therefore not representative of all southern and eastern African 
countries. However, phylogenetic studies require a large sample size from a single 
community to maximise the opportunity to identify transmission clusters. Although several 
similar large-scale studies will be required in other settings to assess the generalisability of 
our results, the differences in HIV prevalence in young men and women in South Africa are 
also present in many southern and eastern African countries (appendix p 4). Findings from a 
phylogenetic study in Rakai, Uganda, showed that a substantial proportion of HIV infections 
were transmitted within married couples.22 A bioinformatics study in Mochudi, Botswana, 
identified acute subepidemics introduced from outside the region between 1997 and 2007.23 
However, both studies did not specifically address the issue of the source of infection in 
young women.
Fourth, our analysis excluded individuals on successful therapy and is therefore skewed to 
more recent infections because only individuals with viral loads greater than 1000 copies per 
mL could be included. Alternatively, this limitation can be viewed as a strength, because the 
data describe the current and recent epidemic with limited contamination from long- 
established infections and people on treatment who pose minimal risk of spreading HIV. The 
high rate of sequencing failure with current sequencing technology in individuals with low 
viral loads will make these kinds of studies much more difficult to do as treatment coverage 
increases. In this community with 42% ART coverage, our large study of almost 10 000 
individuals and more than 1500 sequences identified only 90 male–female clusters. 
Although this number is fewer than expected, it reflects what is possible from large studies 
at this stage of the HIV epidemic when ART is being rapidly rolled out and clusters 
becoming increasingly diffcult to identify. Finally, a potential bias could be the non-response 
rate. In this study, non-response at household and individual levels were within the range 
factored into the design.
Age disparity in sexual relationships has long been postulated as an important contributor to 
HIV transmission in Africa.24 Empirically, age disparity has been difficult to quantify but an 
analysis of a 1998–2000 community survey in Zimbabwe reported a small but significant 
increase in HIV risk in men caused by age-disparate relationships.25 Our phylogenetic 
analysis, which was made possible by the rapidly decreasing cost of gene sequencing, 
provides an empiric demonstration of the key role of the high HIV incidence in adolescent 
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girls and young women transmitted by men (on average 8 years older) as a key component 
of HIV transmission in South Africa.
In several countries, including South Africa, men have been more challenging than women 
to reach with HIV testing and ART because men are often highly mobile while seeking job 
opportunities.26,27 However, other options to reduce HIV transmission are available. 
Prevention efforts need to include clear messages about age-disparate relationships between 
young women and men in their 30s, as part of an overall longer-term effort to change 
community norms in this regard. Over and above existing prevention and treatment 
programmes, three targeted interventions could help to break the cycle of HIV transmission 
in this setting: rapid scale-up of universal testing and treatment of men and women aged 25–
40 years to reduce the risk of these high HIV prevalence groups transmitting HIV; scale-up 
of circumcision in men younger than 25 years to decrease their risk of acquiring HIV in their 
highest risk years; and provision of pre-exposure prophylaxis for young women to empower 
them to reduce the high risk of acquiring HIV. This combination prevention approach 
targeting three points in the transmission cycle could help to reduce HIV incidence in young 
women, an essential initial step to set Africa on the path to the UNAIDS 2030 goal of ending 
AIDS.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Evidence before this study
We searched PubMed for articles published on or before Aug 24, 2016, with the search 
terms “HIV” and “age-disparate” and “Africa”. We applied no date or language 
restrictions. Despite extensive prevention campaigns and antiretroviral therapy (ART) 
scale-up, HIV incidence in adolescent girls and young women in southern and eastern 
Africa remains high. Although age and sex differences in several HIV prevalence studies 
suggested that older men were likely to be an important source of infection for adolescent 
girls and young women, this finding has been disputed in recent studies. Thus, whether 
age disparate sexual partnering is important for HIV transmission in Africa is unclear.
Added value of this study
In this community-wide survey of 9812 individuals in a setting with a high burden of 
HIV, viral sequencing in 1589 HIV-positive individuals who had viral loads greater than 
1000 copies per mL enabled a phylogenetic analysis of clusters of men and women that 
showed a cycle of HIV transmission driven by high rates of HIV acquisition in adolescent 
girls and young women (15–25 years), principally from men close to or in their 30s (an 
average of 8 years older). These men are likely to have acquired HIV from women aged 
25–40 years, who have the highest HIV prevalence. When the current group of adolescent 
girls and young women reach their 30s, they will then constitute the next group of women 
with high HIV prevalence, thereby perpetuating the cycle of HIV transmission to men in 
their 30s who will infect the next cohort of adolescent girls and young women. Our 
findings highlight the importance of age-disparate relationships in driving HIV 
transmission in southern and eastern Africa.
Implications of all the available evidence
The paucity of definitive data about the link between age-disparate sexual partnerships 
and HIV transmission has hampered HIV prevention in southern and eastern Africa. 
Current prevention programmes in South Africa and several other countries have steered 
clear of including this sociobehavioural factor in their prevention messages and education 
programmes. Our results clarify that sexual partnering between adolescent girls or young 
women and older men is a key feature of the sexual networks driving transmission of 
HIV. Our study provides the necessary evidence to guide changes in HIV programmes by 
identifying a combination prevention-and-treatment approach targeting three points in the 
cycle of HIV transmission that could help to reduce HIV incidence in young women, an 
essential initial step to set Africa on the path to the UNAIDS goal of ending AIDS by 
2030.
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HIV prevalence rates in a KwaZulu-Natal community in South Africa by age and gender
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Figure 2. Maximum Likelihood tree for 90 heterosexual transmission clusters
Clusters were with a bootstrap support higher than 90% and whose sequences had an intra-
clade genetic distance <= 4.5%. In total, 123 women were linked to 103 men in the 90 
heterosexual clusters. For better visualization of the clusters, tree is represented using 
proportional branch lengths transformation. The age of the individuals in each transmission 
cluster is presented inside boxes. Boxes are coloured based on gender, where grey represents 
males and red represents females.
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All possible pairings from 90 male-female clusters stratified by the age group. The 
community-based HIV prevalence in each age group is shown in parentheses.
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Schematic presentation of the sexual networks of HIV positive men and women in 
phylogenetically identified heterosexual transmission clusters in a KwaZulu-Natal 
community in South Africa *weighted HIV prevalence
de Oliveira et al. Page 17


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Lancet HIV. Author manuscript; available in PMC 2018 January 01.
